The National Institutes of Health report that the United States government has been stocking up on a radiation sickness drug worth $290 million - but is this really for our own health and safety, or is it for some other purpose? There was a general belief that the large purchase was due to the threat of a nuclear war between Russia and Ukraine.
Nplate aims to improve clotting as well as to prevent hemorrhaging and reduce radiation-induced bleeding, but was its development really only a coincidence? The same agencies and individuals who funded the Wuhan lab that "accidentally" released Covid-19 are behind Nplate. Is it possible that they have knowledge that we do not have?
As part of Project BioShield, Amgen developed Nplate, the trade name for romiplostim, to treat injured blood cells due to acute radiation syndrome. The FDA approved this innovative drug in 2008 and again in 2021 for the treatment of immune thrombocytopenia - an autoimmune disorder resulting in bleeding. The development of Nplate has been supported with substantial funding by government agencies such as BARDA (Biomedical Advanced Research and Development Authority) since the start of Project Bioshield 2004.
As preppers and survivalists, it is always important to be prepared and ready for anything. This recent action by the federal government emphasizes the need for everyone to be prepared for what is next to affect day-to-day life in the western world.